he mission of the Children with Diabetes Foundation is to fund human clinical trials leading to cure and prevention of Type 1 diabetes. We are the venture capitalists of diabetes research, getting new, clinically relevant, innovative research off the ground.
Click here to learn more about us
Click here for information on our research focus

November 25, 2008

The CWD Foundation is soliciting applications from institutions currently participating in human trials of xenotransplantation research or those who are developing  xenotransplantation studies for the cure of Type 1 Diabetes (T1DM). 

Click here for the RFA
Click for guidelines on grant submissions
Other clinically important submissions are welcome

October 21, 2008

The Honorable David Cunliffe, has approved an application from Living Cell Technologies to conduct in New Zealand a Phase I/IIa clinical trial of DiabeCell®, LCT's lead product candidate for the treatment of insulin dependent (Type 1) diabetes.
Read more

April 2008

The CWD Foundation has received a significant contribution from the acquisition of Children with Diabetes by Johnson & Johnson, which will allow us to fund promising human clinical trials to prevent and cure type 1 diabetes.
Read more

February 2008

Living Cell Technologies and US-Based Barbara Davis Center to Collaborate on Diabetes Clinical Trial Program. Living Cell Technologies Limited announced that the Company has signed a term sheet with the Barbara Davis Center for Childhood Diabetes (BDC) to establish a diabetes clinical trial program in Denver, Colorado.
Read more

February 2008

WDF has offered its support in raising funds for LCT's DiabeCell® clinical trials for people with type 1 diabetes.  The foundation has established a fund which allows supporters of diabetes research to contribute tax deductible donations towards the trials.

In the past CWDF has contributed approximately US$ 250,000 towards Professor Elliott's research and LCT's development work. The foundation has also invested in LCT and holds 330,117  shares.
Read more